rethinkTHC Search
Menu
Study breakdown

Adding CBD to a patient medications caused lithium toxicity, revealing a previously unknown drug interaction

Case ReportPreliminary evidence
The takeaway

An autistic patient with Lennox-Gastaut syndrome developed lithium toxicity several weeks after starting CBD (Epidiolex), revealing a clinically important drug-drug interaction between CBD and lithium.

Neurologists prescribing CBD, psychiatrists managing lithium, and pharmacists monitoring drug interactions.

CBD-lithium interaction caused toxicity weeks after CBD initiation

What the researchers found

An autistic patient with LGS and psychiatric comorbidities on multiple medications including lithium developed hypersomnolence, ataxia, and decreased oral intake several weeks after starting CBD. He was found to have lithium toxicity. After lithium was discontinued, symptoms resolved. He remained on CBD and other anti-seizure medications, becoming seizure-free with improved behavior.

Why it matters

CBD drug interactions with anti-seizure medications are increasingly recognized, but this is among the first reports of CBD interacting with a psychiatric medication (lithium). Patients on CBD often take multiple medications, making interaction awareness critical.

The numbers in context

Lithium toxicity developed weeks after CBD initiation; symptoms: hypersomnolence, ataxia, decreased oral intake; resolved after lithium discontinuation; patient became seizure-free on CBD.

How the study worked

Single case report documenting the clinical timeline and management of lithium toxicity precipitated by CBD addition in a patient with complex neuropsychiatric comorbidities.

What this study cannot tell us

Single case report; multiple concurrent medications confound attribution; mechanism of CBD-lithium interaction not confirmed; lithium levels before CBD not reported; cannot determine if interaction is consistent across patients.

How to read the evidence

Preliminary: single case report; clinically important but cannot establish mechanism or frequency.

When this study was published

Published 2020.

The bigger picture

As CBD is prescribed to patients with epilepsy who often have psychiatric comorbidities, the potential for interactions with psychiatric medications needs systematic study. Lithium has a narrow therapeutic index, making any pharmacokinetic interaction dangerous.

Questions still open

  • Does CBD affect lithium renal clearance or absorption? Should lithium levels be routinely monitored when starting CBD?

Common questions

Can CBD interact with psychiatric medications?
Yes. This case report documented lithium toxicity developing weeks after starting CBD (Epidiolex), revealing a previously unknown interaction. Patients on CBD and lithium should have lithium levels monitored closely.
Which medications does CBD interact with?
CBD is known to interact with several anti-seizure medications (especially clobazam and valproate). This case adds lithium to the list. CBD inhibits certain liver enzymes that metabolize other drugs, potentially increasing their blood levels.

Read the original research

Drug-Drug Interactions Between Cannabidiol and Lithium.

Child neurology open, 7, 2329048X20947896

Citation

Singh, Rani K; Dillon, Brittany; Tatum, David A; Van Poppel, Katherine C; Bonthius, Daniel J. (2020). Drug-Drug Interactions Between Cannabidiol and Lithium.. Child neurology open, 7, 2329048X20947896. https://doi.org/10.1177/2329048X20947896

Explore the wider topic